MedPath

Assessing the Predictive Value of High Frequency Algorithm of PURE EP for Low Amplitude Signal Detection

Conditions
Cardiac Arrhythmias
Interventions
Other: PURE EP (Observational Study)
Registration Number
NCT05450302
Lead Sponsor
Kansas City Heart Rhythm Research Foundation
Brief Summary

Prior multicenter study demonstrated superiority of PURE EP to conventional mapping. This superiority was seen when comparing small, fractionated signals of interest, near-field vs far-field distinction, and general signal quality (2). Hence, investigators propose a retrospective study to assess the predictive value of high frequency algorithm (HFA) for identifying local physiologic signal under 0.3 mV distinctive of noise.

Detailed Description

Accurate interpretation of intracardiac EGMs remains essential to the field of electrophysiology (EP). Conventional Electro-anatomical mapping systems (EAMs) have made significant improvements in EGM quality and noise reduction since their emergence, however their use of variable gain amplifiers and high/low pass filters, often provide visualization of low amplitude signals that lead to saturation artifact or necessitate signal clipping.

PURE EPTM (BioSig Technologies, Inc., Westport, CT, USA), in contrast does provide the ability to record this unaltered signal with more customizable display options. Their proprietary amplifier and high-resolution analog-digital converters with Radiofrequency (RF) suppression eliminates the need for gain switching, optimizing resolution of the full range of input signals (1).

Prior multicenter study demonstrated superiority of PURE EP to conventional mapping. This superiority was seen when comparing small, fractionated signals of interest, near-field vs far-field distinction, and general signal quality (2). Hence, investigators propose a retrospective study to assess the predictive value of high frequency algorithm (HFA) for identifying local physiologic signal under 0.3 mV distinctive of noise.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
150
Inclusion Criteria

All patients (male + Female) with age > 18 years from January 2022 till June 2022 will be included in the study.

Exclusion Criteria

All patients in which PURE EP was not used from January 2022 till June 2022.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
PURE EPPURE EP (Observational Study)All patients from January 2022 till June 2022 in whom PURE EP was used at the Kansas City Heart Rhythm Institute, Overland Park, Kansas
Primary Outcome Measures
NameTimeMethod
Predictive value of High Frequency Algorithm - for signals under 0.3mV distinctive of noise1/1/2022 - 6/30/2022

Validate the predictive value of High Frequency Algorithm (HFA) for identifying local physiologic signals under 0.3mV distinctive of noise.

Sensitivity and specificity1/1/2022 - 6/30/2022

Percen of sensitivity and specificity of predicting a small physiologic signal distinctive from noise

Predictive value of High Frequency Algorithm - for signals under 0.1mV distinctive of noise1/1/2022 - 6/30/2022

Validate the predictive value of High Frequency Algorithm (HFA) for identifying local physiologic signals under 0.1mV distinctive of noise

Secondary Outcome Measures
NameTimeMethod
Channel of the Bipolar1/1/2022 - 6/30/2022

It depends on which channel has the low amplitude signal and it may change based on the signal. It is measured by "Horizontal Caliper Mode '' in millivolts in the PURE EP program.

Bipolar amplitude1/1/2022 - 6/30/2022

The measurement tool, specifically within PURE EP, called "Horizontal Caliper Mode" similar to that of recording and mapping systems, will measure the millivolt peak-to-peak amplitude of the bipolar signal, which is identified by its electrode numbers.

Trial Locations

Locations (1)

Kansas City Heart Rhythm Institute

🇺🇸

Overland Park, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath